Literature DB >> 18799575

Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.

Anthony Tanoto Tan1, Elisabetta Loggi, Carolina Boni, Adeline Chia, Adam J Gehring, Konduru S R Sastry, Vera Goh, Paola Fisicaro, Pietro Andreone, Christian Brander, Seng Gee Lim, Carlo Ferrari, Florian Bihl, Antonio Bertoletti.   

Abstract

Repertoire composition, quantity, and qualitative functional ability are the parameters that define virus-specific T-cell responses and are linked with their potential to control infection. We took advantage of the segregation of different hepatitis B virus (HBV) genotypes in geographically and genetically distinct host populations to directly analyze the impact that host and virus variables exert on these virus-specific T-cell parameters. T-cell responses against the entire HBV proteome were analyzed in a total of 109 HBV-infected subjects of distinct ethnicities (47 of Chinese origin and 62 of Caucasian origin). We demonstrate that HBV-specific T-cell quantity is determined by the virological and clinical profiles of the patients, which outweigh any influence of race or viral diversity. In contrast, HBV-specific T-cell repertoires are divergent in the two ethnic groups, with T-cell epitopes frequently found in Caucasian patients seldom detected in Chinese patients. In conclusion, we provide a direct biological evaluation of the impact that host and virus variables exert on virus-specific T-cell responses. The discordance between HBV-specific CD8 T-cell repertoires present in Caucasian and Chinese subjects shows the ability of HLA micropolymorphisms to diversify T-cell responses and has implications for the rational development of therapeutic and prophylactic vaccines for worldwide use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799575      PMCID: PMC2573267          DOI: 10.1128/JVI.01124-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism.

Authors:  A Sette; J Sidney
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

2.  A T cell clone's avidity is a function of its activation state.

Authors:  M D Hesse; A Y Karulin; B O Boehm; P V Lehmann; M Tary-Lehmann
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

Review 3.  Chronic hepatitis B virus infection in Asian countries.

Authors:  I Merican; R Guan; D Amarapuka; M J Alexander; A Chutaputti; R N Chien; S S Hasnian; N Leung; L Lesmana; P H Phiet; H M Sjalfoellah Noer; J Sollano; H S Sun; D Z Xu
Journal:  J Gastroenterol Hepatol       Date:  2000-12       Impact factor: 4.029

4.  Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51.

Authors:  R Thimme; K M Chang; J Pemberton; A Sette; F V Chisari
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia.

Authors:  Y Sobao; K Sugi; H Tomiyama; S Saito; S Fujiyama; M Morimoto; S Hasuike; H Tsubouchi; K Tanaka; M Takiguch
Journal:  J Hepatol       Date:  2001-06       Impact factor: 25.083

Review 6.  Genetic variability in hepatitis B viruses.

Authors:  Karin Kidd-Ljunggren; Yuzo Miyakawa; Alistair H Kidd
Journal:  J Gen Virol       Date:  2002-06       Impact factor: 3.891

7.  Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.

Authors:  Corey B Moore; Mina John; Ian R James; Frank T Christiansen; Campbell S Witt; Simon A Mallal
Journal:  Science       Date:  2002-05-24       Impact factor: 47.728

8.  Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.

Authors:  Erik Depla; Annegret Van der Aa; Brian D Livingston; Claire Crimi; Koen Allosery; Veronique De Brabandere; Jonathan Krakover; Sidharta Murthy; Manley Huang; Scott Power; Lilia Babé; Carol Dahlberg; Denise McKinney; Alessandro Sette; Scott Southwood; Ramilla Philip; Mark J Newman; Lydie Meheus
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

9.  HLA-A2 1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo.

Authors:  Yu Kyeong Hwang; Nam Kyung Kim; Jung Min Park; Ki young Lee; Won Kyo Han; Hyung Il Kim; Hong Seok Cheong
Journal:  Vaccine       Date:  2002-11-01       Impact factor: 3.641

10.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615

View more
  44 in total

Review 1.  Structural and functional distinctiveness of HLA-A2 allelic variants.

Authors:  Kenneth Yuanxiang Chen; Jingxian Liu; Ee Chee Ren
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

2.  Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope.

Authors:  Hsueh-Ling Janice Oh; Adeline Chia; Cynthia Xin Lei Chang; Hoe Nam Leong; Khoon Lin Ling; Gijsbert M Grotenbreg; Adam J Gehring; Yee Joo Tan; Antonio Bertoletti
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

3.  CD8+ T-Cell Response-Associated Evolution of Hepatitis B Virus Core Protein and Disease Progress.

Authors:  George F Gao; Jingmin Zhao; Yu Zhang; Yan Wu; Mengmeng Deng; Dongping Xu; Xiaodong Li; Zhihui Xu; Jun Hu; Han Zhang; Kefang Liu; Yingze Zhao; Feng Gao; Shengli Bi; William J Liu; Songdong Meng
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

4.  Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation.

Authors:  Laura Rivino; Nina Le Bert; Upkar S Gill; Kamini Kunasegaran; Yang Cheng; Damien Zm Tan; Etienne Becht; Navjyot K Hansi; Graham R Foster; Tung-Hung Su; Tai-Chung Tseng; Seng Gee Lim; Jia-Horng Kao; Evan W Newell; Patrick Tf Kennedy; Antonio Bertoletti
Journal:  J Clin Invest       Date:  2018-01-08       Impact factor: 14.808

5.  Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection.

Authors:  Janine Kah; Sarene Koh; Tassilo Volz; Erica Ceccarello; Lena Allweiss; Marc Lütgehetmann; Antonio Bertoletti; Maura Dandri
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

Review 6.  Genetic variation of hepatitis B virus and its significance for pathogenesis.

Authors:  Zhen-Hua Zhang; Chun-Chen Wu; Xin-Wen Chen; Xu Li; Jun Li; Meng-Ji Lu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 7.  MiR-122 in hepatic function and liver diseases.

Authors:  Jun Hu; Yaxing Xu; Junli Hao; Saifeng Wang; Changfei Li; Songdong Meng
Journal:  Protein Cell       Date:  2012-05-18       Impact factor: 14.870

Review 8.  Immunopathogenesis of chronic hepatitis B.

Authors:  Irina P Balmasova; Nikolay D Yushchuk; Ospan A Mynbaev; Nageswara R Alla; Elena S Malova; Zhongjie Shi; Chang-Lu Gao
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

9.  Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.

Authors:  Laura Rivino; Emmanuelle A P Kumaran; Vojislav Jovanovic; Karen Nadua; En Wei Teo; Shyue Wei Pang; Guo Hui Teo; Victor Chih Hao Gan; David C Lye; Yee Sin Leo; Brendon J Hanson; Kenneth G C Smith; Antonio Bertoletti; David M Kemeny; Paul A MacAry
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

10.  Associations between HLA class I alleles and escape mutations in the hepatitis B virus core gene in New Zealand-resident Tongans.

Authors:  William G H Abbott; Peter Tsai; Euphemia Leung; Alex Trevarton; Malakai Ofanoa; John Hornell; Edward J Gane; Stephen R Munn; Allen G Rodrigo
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.